Bayer Appeals Yasmin Contraceptive Patent Invalidity
Bayer Schering Pharma AG has appealed a judge's recent finding that the patent at issue in the lawsuit against Barr Laboratories Inc. over the $488 million U.S. market for the contraceptive...To view the full article, register now.
Already a subscriber? Click here to view full article